Michael Andreini is the president and chief executive officer of the Multiple Myeloma Research Foundation (MMRF) and the Multiple Myeloma Research Consortium (MMRC).
Michael brings nearly 15 years of strategic consulting and operational experience in the life sciences industry.
Prior to joining the MMRF, Michael was an associate principal at IQVIA in the consulting services organization where he developed strategies for biopharma, medical device, and non-profit organizations to drive innovation and operational excellence across a diverse set of business challenges, including R&D and launch strategy, commercial due diligence and portfolio optimization, and organizational effectiveness.
Before joining IQVIA, Michael worked at Fuld & Company, a boutique consulting firm specializing in competitive intelligence and strategy, and prior to that, at Siemens Healthcare Diagnostics in the Global Technical Operations group, where he resolved technical issues for immunoassay reagents and systems.
Michael earned a BA in chemistry with a minor concentration in economics from Colgate University.
